Phase 2 data from PTC Therapeutics showed that the Novartis-partnered Huntington’s disease asset slowed progression by more ...
Dr. Rakesh Parekh was in his mid-40s when he first noticed something was wrong: During his workouts, his left arm was weaker and struggled to keep up. Initially, Parekh, an emergency medicine doctor ...
A new drug may slow progression of — and even reverse — symptoms of a rare form of amyotrophic lateral sclerosis, or ALS, a new study published Monday finds. The drug, tofersen, targets a very ...
Add Yahoo as a preferred source to see more of our stories on Google. A Colorado team has found that sargramostim, a long used immune drug, cut a blood marker of neuron death by 40 percent in people ...
Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients. Their decision stands in contrast to Medicare, which will wind up covering ...
Long before memory problems appear, your brain may already be losing neurons. That is the unsettling message from new work by scientists at the University of Colorado Anschutz Medical Campus, who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results